Calorimetric analysis of lisinopril binding to angiotensin I-converting enzyme

被引:20
作者
Téllez-Sanz, R
García-Fuentes, L
Barón, C [1 ]
机构
[1] Univ Almeria, Fac Ciencias Expt, Dept Quim Fis Bioquim & Quim Inorgan, Almeria 04120, Spain
[2] Inst Biotecnol de Granada, Granada, Spain
关键词
angiotensin I-converting enzyme; lisinopril; microcalorimetry; binding;
D O I
10.1016/S0014-5793(98)00069-6
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Isothermal titration microcalorimetry has been used to measure changes in enthalpy and heat capacity for binding of lisinopril to the angiotensin I-converting enzyme (ACE; EC 3.4.15.1) and to its apoenzyme at pH 7.5 over a temperature range of 15-30 degrees C. Calorimetric measurements indicate that lisinopril binds to two sites in the monomer of both hole-and apo-ACE. Binding of lisinopril to both systems is enthalpically unfavorable and, thus, is dominated by a large positive entropy change, The enthalpy change of binding is strongly temperature-dependent for both hole-and ape-ACE, arising from a large heat capacity change of binding equal to -2.4 +/- 0.2 kJ/K/(mol of monomeric hole-ACE) and to -1.9 +/- 0.2 kJ/K/(mol of monomeric ape-ACE), respectively, The negative values of Delta C-p for both systems are consistent with burial of a large non-polar surface area upon binding. Although the binding of lisinopril to hole-and ape-ACE is favored by entropy changes, this is more positive for the holoenzyme, Thus, the interaction between Zn2+ and lisinopril results in a higher affinity of the holoenzyme for this drug due to a more favorable entropic contribution. (C) 1998 Federation of European Biochemical Societies.
引用
收藏
页码:75 / 80
页数:6
相关论文
共 46 条
[1]  
BARON C, 1989, J BIOL CHEM, V264, P12872
[2]  
BELDENT V, 1993, J BIOL CHEM, V268, P26428
[3]   A DEEPLY RECESSED ACTIVE-SITE IN ANGIOTENSIN-CONVERTING ENZYME IS INDICATED FROM THE BINDING CHARACTERISTICS OF BIOTIN-SPACER-INHIBITOR REAGENTS [J].
BERNSTEIN, KE ;
WELSH, SL ;
INMAN, JK .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1990, 167 (01) :310-316
[4]   Affinity of angiotensin I-converting enzyme (ACE) inhibitors for N- and C-binding sites of human ACE is different in heart, lung, arteries, and veins [J].
Bevilacqua, M ;
Vago, T ;
Rogolino, A ;
Conci, F ;
Santoli, E ;
Norbiato, G .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1996, 28 (04) :494-499
[5]  
BULL HG, 1985, J BIOL CHEM, V260, P2952
[6]  
CUSHMAN D W, 1987, Journal of Cardiovascular Pharmacology, V10, pS17
[7]   DESIGN OF POTENT COMPETITIVE INHIBITORS OF ANGIOTENSIN-CONVERTING ENZYME - CARBOXYALKANOYL AND MERCAPTOALKANOYL AMINO-ACIDS [J].
CUSHMAN, DW ;
CHEUNG, HS ;
SABO, EF ;
ONDETTI, MA .
BIOCHEMISTRY, 1977, 16 (25) :5484-5491
[8]  
Deddish PA, 1996, J PHARMACOL EXP THER, V279, P1582
[9]  
Doyle ML, 1995, METHOD ENZYMOL, V259, P183
[10]   ANGIOTENSIN-CONVERTING ENZYME - NEW CONCEPTS CONCERNING ITS BIOLOGICAL ROLE [J].
EHLERS, MRW ;
RIORDAN, JF .
BIOCHEMISTRY, 1989, 28 (13) :5311-5318